Topics

Everything's Special At US FDA: Priority NDA/BLA Filings Surge

12:21 EDT 12 Sep 2019 | SCRIP

The FY 2018 PDUFA performance report also indicates that applications with standard assessments fell compared to long-term averages.

      

Related Stories

 

Original Article: Everything's Special At US FDA: Priority NDA/BLA Filings Surge

NEXT ARTICLE

More From BioPortfolio on "Everything's Special At US FDA: Priority NDA/BLA Filings Surge"

Quick Search